See up to 3 months of BLCO. The 7-day demo opens the 1M and 3M ranges and puts BLCO on your watchlist.
Start 7-day demoLatest BLCO insider trades
About Bausch & Lomb Corp (BLCO)
The SEC lists Bausch & Lomb Corp under CIK 0001860742, in ophthalmic goods. We track it alongside the rest of the Health Care sector.
BLCO Form 4 activity by transaction type, last 90 days
| Form 4 transaction type | Transactions | Shares | Total value |
|---|---|---|---|
| Open-market sale | 3 | 71,459 | $1.19M |
| Grant or award | 10 | 464,719 | |
| Tax withholding / forfeiture | 1 | 4,231 |
Dollar totals cover purchases and sales only (codes P and S). Grants, option exercises, gifts and tax withholding are counted in shares, because none of them is a trade at a market price.
BLCO insider transactions (Form 4)
3286 Form 4 filings on record, the earliest from Oct 1, 2024, newest first. Filing history page 1 of 3.
| Date | Insider | Transaction | Security | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Barbara Trebbi - Director | Grant or award | Common Shares, No Par Value | 11,776 footnote F1 | $0.00 | - | |
| ||||||
| Laurence E. Paul - Director | Grant or award | Common Shares, No Par Value | 11,776 footnote F1 | $0.00 | - | |
| ||||||
| Robert J. Chersi - Director | Grant or award | Common Shares, No Par Value | 11,776 footnote F1 | $0.00 | - | |
| ||||||
| Frederick Munsch - Officer | Open-market sale | Common Shares, No Par Value | 52,900 footnote F1 | $16.78 | $888K | |
| ||||||
| Eschenbach Andrew C. von - Director | Open-market sale | Common Shares, No Par Value | 12,500 | $16.50 footnote F1 | $206K | |
| Eschenbach Andrew C. von - Director | Open-market sale | Common Shares, No Par Value | 6,059 | $16.58 footnote F2 | $100K | |
| ||||||
| Andrew J. Stewart - Officer | Grant or award | Common Shares, No Par Value | 16,778 footnote F1 | $0.00 | - | |
| ||||||
| Frederick Munsch - Officer | Grant or award | Common Shares, No Par Value | 9,091 footnote F1 | $0.00 | - | |
| ||||||
| Yehia Hashad - Officer | Grant or award | Common Shares, No Par Value | 20,973 footnote F1 | $0.00 | - | |
| ||||||
| Sam Eldessouky - Officer | Grant or award | Common Shares, No Par Value | 50,335 footnote F1 | $0.00 | - | |
| ||||||
| Luc Bonnefoy - Officer | Grant or award | Common Shares, No Par Value | 16,778 footnote F1 | $0.00 | - | |
| ||||||
| A. Robert D. Bailey - Officer | Grant or award | Common Shares, No Par Value | 33,557 footnote F1 | $0.00 | - | |
| ||||||
| Brent L. Saunders - Officer | Tax withholding / forfeiture | Common Shares, No Par Value | 4,231 footnote F1 | $16.76 | $71K | |
| Brent L. Saunders - Officer | Grant or award | Common Shares, No Par Value | 281,879 footnote F2 | $0.00 | - | |
| ||||||
| Luc Bonnefoy - Officer | Tax withholding / forfeiture | Common Shares, No Par Value | 1,008 footnote F1 | $15.08 | $15K | |
| ||||||
| Eschenbach Andrew C. von - Director | Grant or award | Common Shares, No Par Value | 15,842 footnote F1 | $15.78 | $250K | |
| ||||||
| Thomas W. Ross Sr. - Director | Grant or award | Common Shares, No Par Value | 15,842 footnote F1 | $15.78 | $250K | |
| ||||||
| Russel C. Robertson - Director | Grant or award | Common Shares, No Par Value | 15,842 footnote F1 | $15.78 | $250K | |
| ||||||
| Grant or award | Common Shares, No Par Value | 15,842 footnote F1 | $15.78 | $250K | ||
| ||||||
| Grant or award | Common Shares, No Par Value | 15,842 footnote F1 | $15.78 | $250K | ||
| ||||||
| Sarah B. Kavanagh - Director | Grant or award | Common Shares, No Par Value | 15,842 footnote F1 | $15.78 | $250K | |
| ||||||
| Steven H. Collis - Director | Grant or award | Common Shares, No Par Value | 15,842 footnote F1 | $15.78 | $250K | |
| ||||||
| Grant or award | Common Shares, No Par Value | 15,842 footnote F1 | $15.78 | $250K | ||
| ||||||
| Eduardo Alfonso - Director | Grant or award | Common Shares, No Par Value | 15,842 footnote F1 | $15.78 | $250K | |
| ||||||
| Brent L. Saunders - Officer | Tax withholding / forfeiture | Common Shares, No Par Value | 2,886 footnote F1 | $15.92 | $46K | |
| ||||||
| Sam Eldessouky - Officer | Tax withholding / forfeiture | Common Shares, No Par Value | 63,938 footnote F1 | $16.00 | $1.02M | |
| ||||||
| Yehia Hashad - Officer | Tax withholding / forfeiture | Common Shares, No Par Value | 13,664 footnote F1 | $16.00 | $219K | |
| ||||||
| Frederick Munsch - Officer | Tax withholding / forfeiture | Common Shares, No Par Value | 8,673 footnote F1 | $16.00 | $139K | |
| ||||||
| Luc Bonnefoy - Officer | Tax withholding / forfeiture | Common Shares, No Par Value | 11,970 footnote F1 | $16.00 | $192K | |
| ||||||
| Russel C. Robertson - Director | Grant or award | Common Shares, No Par Value | 1,611 footnote F1 | $15.90 | $26K | |
| ||||||
| Grant or award | Common Shares, No Par Value | 1,375 footnote F1 | $15.90 | $22K | ||
| ||||||
| Steven H. Collis - Director | Grant or award | Common Shares, No Par Value | 1,415 footnote F1 | $15.90 | $22K | |
| ||||||
Recent BLCO Form 144 notices of proposed sale
3An insider files Form 144 before selling restricted or control stock. It announces a planned sale. If the sale goes ahead, it shows up later on a Form 4.
| Filed | Filer | Relationship | Shares | Market value | Notice |
|---|---|---|---|---|---|
| Ling Karen | Former Director | 4,500 | $76K | View on EDGAR | |
| Munsch Frederick | Officer | 52,900 |
BLCO insider trading FAQ
What is the latest insider trade for BLCO?
Bausch & Lomb Corp (BLCO) had 12 insider filings in the last 90 days, with the most recent on 2026-08-14. The full record for BLCO runs to 86 Form 4 filings, the earliest from 2024-10-01. InsiderAlpha adds new Form 4, Form 144 and 8-K filings as they arrive from SEC EDGAR.
How many insiders are buying BLCO stock?
No insider purchases of BLCO were filed in the last 90 days. 10 purchases are on record for this company.
How many insiders are selling BLCO stock?
3 insider sales of BLCO were filed in the last 90 days, totaling $1.19M.
Where can I see BLCO SEC filings (Form 4, 10-K, 10-Q, 8-K)?
This page collects BLCO Form 4 insider transactions, Form 144 sale notices and 8-K filings in one place. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
More Health Care companies with insider activity
Recent insider filings
10The EDGAR links open each original Form 4, so you can check any number on this page against the filing it came from.
- - Barbara Trebbi view on EDGAR
- - Laurence E. Paul view on EDGAR
- - Robert J. Chersi view on EDGAR
- - Frederick Munsch view on EDGAR
- - Eschenbach Andrew C. von view on EDGAR
- - Andrew J. Stewart view on EDGAR
- - Frederick Munsch view on EDGAR
- - Yehia Hashad view on EDGAR
- - Sam Eldessouky view on EDGAR
Related companies with recent insider activity
Learn more
- Insider selling: signal or noise?
- Why most insider sales are routine, and the few patterns worth a second look.
- Form 144 vs Form 4
- A Form 144 announces a planned sale; the Form 4 reports it after it happens.
- Insider activity in Health Care
- Where BLCO's peers are being bought and sold.
- Every recent Form 4
- The market-wide feed, updated as filings arrive from SEC EDGAR.
Follow BLCO with a 7-day demo
- BLCO on your watchlist
- Every BLCO Form 4 filing on record
- Up to 3 months of BLCO price history
- The daily trading plan of ranked insider buys, on a delay, with the plan archive